Animal models to explore the effects of glucocorticoids on skeletal growth and structure

Claire L Wood1, Ondrej Soucek2,3, Sze C Wong4

  • 1Division of Developmental BiologyRoslin Institute, University of Edinburgh, Edinburgh, UK.

Insights

Glucocorticoids (GCs) effectively treat chronic conditions but cause bone issues like osteoporosis. This review examines animal models for studying GC effects on skeletal development and growth retardation.

Area of Science:

  • Biomedical Science
  • Pharmacology
  • Skeletal Biology

Background:

  • Glucocorticoids (GCs) are widely used for chronic conditions.
  • GCs induce significant adverse skeletal effects, including osteoporosis and growth retardation.
  • The precise mechanisms behind GC-induced skeletal damage remain unclear.

Purpose of the Study:

  • To review existing animal models for studying glucocorticoid-induced skeletal changes.
  • To highlight methodologies used in pre-clinical investigations of GC effects on bone.
  • To identify the need for well-characterized models to evaluate interventions.

Main Methods:

  • Literature review of experimental studies.
  • Analysis of various protocols for inducing GC-related bone conditions in animal models.
  • Summary of techniques used to assess skeletal development and bone changes.

Main Results:

  • Current animal models for GC-induced skeletal effects have limitations.
  • No single established model effectively captures all aspects of GC-induced bone pathology.
  • Different protocols present unique advantages and disadvantages.

Conclusions:

  • A well-characterized pre-clinical model is crucial for evaluating new treatments.
  • Further research is needed to establish optimal animal models for GC skeletal toxicity studies.
  • Understanding these models is vital for developing effective interventions against GC-induced bone damage.

Related Concept Videos